Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alpha-tocotrienol Quinone
2. Epi-743
1. 1213269-98-7
2. Epi-743
3. Alpha-tocotrienol Quinone
4. Epi 743
5. Alpha Tocotrienol Quinone
6. .alpha.-tocotrienol Quinone
7. 6o85fk9i0x
8. 2,5-cyclohexadiene-1,4-dione, 2-((3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl)-3,5,6-trimethyl-
9. 2-((r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
10. Vatiquinone [usan]
11. Vatiquinone [usan:inn]
12. Unii-6o85fk9i0x
13. Vatiquinone [inn]
14. Vatiquinone [jan]
15. Vatiquinone (jan/usan)
16. Schembl503125
17. (r)-alpha-tocotrienol Quinone
18. Chembl1812161
19. Schembl14639355
20. Dtxsid90153231
21. Bcp21072
22. Ex-a5566
23. Db11917
24. 2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
25. Hy-16772
26. Cs-0012384
27. D10407
28. A937320
29. Q27265220
30. Epi 743;epi743; Vatiquinone; Alpha-tocotrienol Quinone
31. 2-((3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
32. 2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dion
| Molecular Weight | 440.7 g/mol |
|---|---|
| Molecular Formula | C29H44O3 |
| XLogP3 | 7.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 12 |
| Exact Mass | 440.32904526 g/mol |
| Monoisotopic Mass | 440.32904526 g/mol |
| Topological Polar Surface Area | 54.4 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 857 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of Leigh syndrome
Treatment of mitochondrial disease
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Vatiquinone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vatiquinone, including repackagers and relabelers. The FDA regulates Vatiquinone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vatiquinone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vatiquinone supplier is an individual or a company that provides Vatiquinone active pharmaceutical ingredient (API) or Vatiquinone finished formulations upon request. The Vatiquinone suppliers may include Vatiquinone API manufacturers, exporters, distributors and traders.
click here to find a list of Vatiquinone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vatiquinone DMF (Drug Master File) is a document detailing the whole manufacturing process of Vatiquinone active pharmaceutical ingredient (API) in detail. Different forms of Vatiquinone DMFs exist exist since differing nations have different regulations, such as Vatiquinone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vatiquinone DMF submitted to regulatory agencies in the US is known as a USDMF. Vatiquinone USDMF includes data on Vatiquinone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vatiquinone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vatiquinone suppliers with USDMF on PharmaCompass.
Vatiquinone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vatiquinone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vatiquinone GMP manufacturer or Vatiquinone GMP API supplier for your needs.
A Vatiquinone CoA (Certificate of Analysis) is a formal document that attests to Vatiquinone's compliance with Vatiquinone specifications and serves as a tool for batch-level quality control.
Vatiquinone CoA mostly includes findings from lab analyses of a specific batch. For each Vatiquinone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vatiquinone may be tested according to a variety of international standards, such as European Pharmacopoeia (Vatiquinone EP), Vatiquinone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vatiquinone USP).
LOOKING FOR A SUPPLIER?
